Patent Licensing
Cross-License
Two companies each needing the other's patents grant each other licenses — avoiding infringement suits, resolving blocking patent situations, and enabling both parties to compete freely. Financial balancing payments equalize portfolio value.
FAQ
What is a cross-license and how does it work?
A cross-license is a bilateral (or multilateral) patent license agreement in which each party grants the other party (or parties) the right to use its patent portfolio — or a defined subset of it — in exchange for reciprocal rights to the other's patents. HOW IT WORKS: Party A owns patents that Party B needs to practice its technology; Party B owns patents that Party A needs; instead of each suing the other for infringement, they negotiate a cross-license; the license grants each party the right to make, use, sell, and import products covered by the other's patents; financial balancing payments (royalties or lump sums) flow in one direction if the portfolios have unequal value; RESOLUTION OF BLOCKING PATENTS: cross-licenses are the primary resolution mechanism for blocking patent situations — where a pioneer patent and an improvement patent each prevent the other's owner from practicing the improved technology; INDUSTRY-WIDE USE: nearly every major technology company participates in cross-license programs; IBM has cross-licenses with hundreds of companies covering most of its foundational technology portfolio; Qualcomm, Ericsson, Nokia, InterDigital, and others have extensive cross-licensing programs with device manufacturers; SCOPE: cross-licenses are typically defined by: (a) PATENT PORTFOLIO SCOPE — which patents are licensed (all patents, a specific field, patents filed before a date); (b) FIELD OF USE — what the recipient can do with the licensed patents; (c) TERRITORY — geographic coverage; (d) TERM — how long the license runs; (e) SUBLICENSING — whether the licensee can sublicense to affiliates or third parties.
How is a cross-license valued and balanced?
Cross-license valuation is one of the most complex aspects of IP strategy — particularly when portfolios are unequal in size or value: PORTFOLIO VALUATION METHODS: (1) COUNTING APPROACH: count patents in each portfolio and compare; crude but common in initial negotiations; (2) CLAIMS APPROACH: count the claims most likely to be infringed by the other party's products; broader, more targeted claims are worth more than narrow or weak patents; (3) ROYALTY RATE APPROACH: calculate what each party would charge the other for a unilateral license at arm's length; the net difference (after offsetting the parties' cross-royalties) is the balancing payment; (4) COMPARABLE TRANSACTION: look at comparable licenses in the same technology space; FRAND rates, industry standard rates, or prior arm's-length licenses; (5) LITIGATION RISK-WEIGHTED VALUE: consider the probability each patent would survive validity challenge and be found infringed; discount portfolio value by invalidity risk; FINANCIAL BALANCING: if Party A's portfolio is worth $50M/year in license fees and Party B's is worth $20M/year, the cross-license might require Party B to pay a 'balancing royalty' of $30M/year (the difference); alternatively, the parties negotiate a lump-sum settlement for a defined period; MOST FAVORED LICENSEE (MFL) CLAUSES: a party may insist on an MFL clause — if either party later grants a more favorable license to a third party, the cross-licensee gets the same terms; this prevents a party from signing a low-value cross-license and then offering a more valuable license to a third party; MFL clauses complicate future licensing negotiations.
What are the key provisions in a cross-license agreement?
Cross-license agreements are complex commercial contracts with several provisions that require careful negotiation: (1) GRANT CLAUSE: defines what each party is receiving — make, use, sell, import rights; within a specific field of use; within specific territories; under specific patents or patent families; (2) PORTFOLIO DEFINITION: which patents are included (all patents as of the effective date; patents filed before a certain date; patents in a specific technology field); whether future patents are included; how acquired patents are treated; (3) TERM: typically co-extensive with the life of the licensed patents; renewable; subject to termination provisions; (4) FINANCIAL TERMS: balancing royalties (running or lump sum); payment currency; audit rights; interest on late payments; (5) GRANTBACK CLAUSES: whether each party must license future improvements under the same cross-license; grantback provisions may be MANDATORY (automatic license to future improvements) or OPTIONAL; mandatory grantbacks are scrutinized under antitrust law (may be coercive if the stronger party imposes on a weaker licensee); (6) SUBLICENSING RIGHTS: whether the licensed rights extend to subsidiaries and affiliates (usually yes); whether third-party sublicensing is permitted (usually no without consent); (7) INFRINGEMENT HISTORY RELEASE: a release of past infringement claims — defines the cutoff date and scope of claims released; (8) ASSIGNMENT: typically not assignable without consent except with the entire business; bankruptcy issues — § 365(n) elections by licensees if licensor goes bankrupt; (9) AUDIT RIGHTS: the right to audit the other party's royalty-bearing activities; (10) DISPUTE RESOLUTION: arbitration or litigation; governing law and venue.
What are antitrust concerns with cross-licensing?
Cross-license agreements can raise antitrust concerns if they are used to allocate markets, fix prices, or exclude competition: LEGITIMATE VS. ANTICOMPETITIVE: most cross-licenses are procompetitive — they allow both parties to use each other's technology, produce better products, and compete; courts and regulators generally view cross-licenses favorably; POTENTIAL ANTITRUST ISSUES: (1) MARKET ALLOCATION: if a cross-license includes provisions where each party agrees to stay out of certain product markets or geographies, this is naked market allocation — per se illegal under Sherman Act § 1; (2) PRICE-FIXING: if cross-licensees agree on licensing rates for third parties (coordinating their licensing terms), this can be price-fixing; patent pools with cartel-like pricing structures raise similar concerns; (3) EXCLUSIONARY EFFECTS: if a cross-license between dominant players effectively excludes smaller players who lack patents to trade, it can be exclusionary; (4) MANDATORY GRANTBACK COERCION: requiring a licensee to grant back all future improvements to the licensor for free — particularly when the licensor is dominant — can deter the licensee from investing in R&D; REGULATORY SCRUTINY: DOJ Antitrust Division and FTC have guidelines on patent cross-licenses and pools; EU competition law (Article 101 TFEU) and Technology Transfer Block Exemption Regulation (TTBER 316/2014) apply to cross-licenses in EU; SAFE HARBOR: cross-licenses between non-competitors generally receive lighter scrutiny; cross-licenses between competitors in the same field receive more scrutiny, particularly for market allocation and grantback provisions.
How are cross-licenses negotiated in practice?
Cross-license negotiations are often multi-year processes involving technical, legal, and business teams: INITIATION: typically begins with a 'patent assertion' or 'patent notice letter' from one party to another; the recipient responds by asserting its own portfolio — establishing the basis for negotiation; sometimes begins with litigation — cross-licenses often resolve patent suits between large technology companies; NEGOTIATION PROCESS: (1) PORTFOLIO REVIEW: each party's patent team reviews the other's portfolio to assess relevance, breadth, validity, and coverage of the counterparty's products; (2) CLAIM CHARTS: each party maps the other's patents to its own products to establish infringement exposure; (3) VALUATION: both parties independently value the portfolios and develop financial proposals; (4) BUSINESS JUDGMENT: senior business leaders decide whether to pay a balancing royalty or fight (litigation); the value of avoiding litigation, maintaining product launches, and preserving business relationships drives this decision; NEGOTIATION TACTICS: (1) PORTFOLIO BUILDING LEVERAGE: companies that invest in R&D and file patents have more leverage in cross-license negotiations — more patents to trade; (2) CLAIM QUALITY: a smaller portfolio with strong, clearly-infringed claims may outvalue a large portfolio of weak patents; (3) LITIGATION AS LEVERAGE: filing a lawsuit (or threatening one credibly) accelerates negotiations; (4) INDUSTRY NORMS: in semiconductor, wireless, and computing industries, cross-licensing is so standard that the negotiation focuses on financial balancing, not whether to cross-license; CONCLUSION: typically, a multi-year Agreement for Cross-License of Patents covering both parties' relevant patent portfolios, with financial terms, release of past claims, and a term extending to patent expiry.
Related Guides